Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)

Authors

Ahmad Monabati (ORCID: https://orcid.org/0000-0002-3378-1937)
Massoud Vosough (ORCID: https://orcid.org/0000-0002-5396-4714)
Firoozeh Abtahi (ORCID: https://orcid.org/0000-0002-8202-465X)
Yahya Kiwan
Mohammad Kasaei (ORCID: https://orcid.org/0000-0001-6574-7568)
Sheik Dowlut
Anthony Mathur (ORCID: https://orcid.org/0000-0001-7941-9653)
Armin Attar (ORCID: https://orcid.org/0000-0002-4133-4870)
Negar Azarpira (ORCID: https://orcid.org/0000-0002-5549-0057)
Seyed Alireza Mirhosseini (ORCID: https://orcid.org/0009-0000-3920-8640)

Institutions

Queen Mary University of London (GB)
Shiraz University of Medical Sciences (IR)
Royan Institute (IR)
Barts Health NHS Trust (GB)
Academic Center for Education, Culture and Research (IR)
University of Sharjah (AE)
William Harvey Research Institute (GB)

Publication Details

Journal: BMJ
Published: 2025-10-29
DOI: https://doi.org/10.1136/bmj-2024-083382
Citations: 4
Primary Topic: Mesenchymal stem cell research
Type: article
Field-Weighted Citation Impact: 6.50

Funders

Shiraz University of Medical Sciences
Shiraz University
National Institute for Medical Research Development

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)

Ahmad Monabati, Massoud Vosough, Firoozeh Abtahi, Yahya Kiwan et al.

Oct 29, 2025

4 citations

BMJ

Mesenchymal stem cell research

6.50

article

Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)

Ahmad Monabati, Massoud Vosough, Firoozeh Abtahi, Yahya Kiwan, Mohammad Kasaei, Sheik Dowlut, Anthony Mathur, Armin Attar, Negar Azarpira, Seyed Alireza Mirhosseini

October 29, 2025article en

4 citations

Abstract

No abstract available for this paper.

BMJVol. 391

Queen Mary University of London (GB), Shiraz University of Medical Sciences (IR), Royan Institute (IR), Barts Health NHS Trust (GB), Academic Center for Education, Culture and Research (IR), University of Sharjah (AE), William Harvey Research Institute (GB)

Shiraz University of Medical Sciences, Shiraz University, National Institute for Medical Research Development

Openalex Percentile: Top 3%

Mesenchymal stem cell research

6.50

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) — Ahmad Monabati, Massoud Vosough, et al. · BMJ (2025) | TGRS Research Map | TGRS